MTOR and non-small cell lung carcinoma: BCAP31 has been shown to have a substantial role in the advancement of non-small cell lung cancer (NSCLC) by facilitating the migration as well as invasion with regard to NSCLC cells via the Akt/mTOR/p70S6K pathway (9).